Search results
Surprising Health Conditions Our Favorite Celebs Struggle With
Cheapism via AOL· 9 hours agoCheapism Discrete Diseases Being in the public eye isn’t for the faint of heart. Celebrities...
Microneedle Magic: New Alopecia Treatment Can Reverse Hair Loss
SciTechDaily· 2 hours agoResearchers at MIT, Brigham and Women’s Hospital, and Harvard Medical School have developed a...
ADVERTISING: Advertorial — Auto-immune insights
Coeur d'Alene Press· 1 day agoFrom a Western Medical perspective, an autoimmune disease is a condition in which the immune system mistakenly attacks the body’s own cells, tissues and...
Immunocore Holdings PLC Reports Q1 2024 Earnings: Misses EPS Estimates, Surpasses Revenue Forecasts
GuruFocus.com via Yahoo Finance· 20 hours agoOn May 8, 2024, Immunocore Holdings PLC (NASDAQ:IMCR) disclosed its...2024, through its 8-K filing....
Zenas, with new funding, aims dual-targeting antibody at lupus and MS
BioPharma Dive via Yahoo Finance· 2 days agoThe $200 million round is the latest evidence that surging interest in autoimmune disease cell...
...Present the Phase I/II Study of MHB088C (B7-H3 ADC) for the Treatment of Patients with Recurrent...
FOX21 Colorado Springs· 22 hours agoMinghui Pharmaceutical, Inc., a late-stage clinical biopharmaceutical company focused on autoimmune diseases and oncology, will feature Dr. Lin Shen from ...
Teen stricken with rare paralyzing disease shares her journey of recovery
ABC 7 Gulfshore News· 1 day agoA few weeks after a viral infection, a 17-year-old is diagnosed with a rare disease that paralyzes...
Autoimmune conditions linked to reactivated X chromosome genes
New Scientist· 6 days agoFemale mammals have a higher risk of developing autoimmune conditions such as lupus because extra...
Q1 2024 Viridian Therapeutics Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 6 hours agoThis new start market also means that all patients experienced symptoms, we'll have the opportunity to choose what available treatment options with no chronic treatment ...
Head-to-head Superiority to High-dose Dulaglutide: Innovent's First Phase 3 Clinical Trial of...
FOX 23 News Albany· 8 hours agoInnovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that...
